Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Rectal Neoplasms × Ascorbic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms, Squamous Cell 1 Liver Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Oxaliplatin 41 Fluorouracil 36 Capecitabine 36 Leucovorin 27 Radiotherapy 24 Irinotecan 19 Chemoradiotherapy 12 Bevacizumab 12 Cetuximab 11 Neoadjuvant Therapy 10 Folfox protocol 10 Chemotherapy, Adjuvant 10 Laparoscopy 9 Drug Therapy 9 XELOX 6 Surgical Procedures, Operative 6 Robotic Surgical Procedures 5 Radiotherapy, Intensity-Modulated 4 Radiation 4 Mastectomy, Segmental 4 durvalumab 3 Surveys and Questionnaires 3 Simvastatin 3 Preoperative Exercise 3 Panitumumab 3 Magnetic Resonance Spectroscopy 3 Indocyanine Green 3 Gemcitabine 3 FOLFOXIRI protocol 3 tislelizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04801511 2021-03-17

CORT

Zhongnan Hospital

Phase 2 Unknown

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡